Cerebrospinal fluid tau, phospho‐tau181 and β‐amyloid1−42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease
- 23 January 2007
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 14 (2), 168-173
- https://doi.org/10.1111/j.1468-1331.2006.01593.x
Abstract
The aim of the present study was the quantitation of total tau protein (tau(T)), tau phosphorylated at threonine 181 (tau(P-181)) and beta-amyloid(1-42) (Abeta42) in the cerebrospinal fluid (CSF) of patients with idiopathic normal pressure hydrocephalus (iNPH), Alzheimer's disease (AD) and controls. Double sandwich ELISAs (Innogenetics) were used for the measurements. Total tau was significantly increased in iNPH and highly increased in AD as compared with the control group, whilst Abeta42 was decreased in both diseases. CSF tau(P-181) levels were significantly increased only in AD, but not in iNPH as compared with the controls. A cut-off level for tau(T) at 300 pg/ml, successfully discriminated AD from normal aging with a 95.8% specificity and 91% sensitivity; whilst the tau(P-181)/tau(T) ratio (cut-off value 0.169) was more specific (100%) but less sensitive (92.5%). For the discrimination of iNPH from AD tau(T) achieved low specificity (77.8%) but high sensitivity (92.5%), whilst tau(P-181) (cut-off value 47.4) was both sensitive and specific (88.7% and 86.7% respectively) for the discrimination of these disorders. The present study, despite being clinical, supports the notion that CSF tau(P-181) alone or in combination with tau(T) may be a useful marker in the discrimination of iNPH from AD.Keywords
This publication has 27 references indexed in Scilit:
- Immunoreactivities of amyloid ? peptide(1?42) and total ? protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalusJournal of Neural Transmission, 2003
- CSF markers for incipient Alzheimer's diseaseThe Lancet Neurology, 2003
- Predictors of outcome in patients with normal-pressure hydrocephalusJournal of Clinical Neuroscience, 2003
- Tau protein in cerebrospinal fluid (CSF): a blood–CSF barrier related evaluation in patients with various neurological diseasesNeuroscience Letters, 2001
- Increased Cerebrospinal Fluid Tau Protein in Multiple SclerosisEuropean Neurology, 2000
- Tau protein is a potential biological marker for normal pressure hydrocephalusPsychiatry and Clinical Neurosciences, 2000
- The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimerʼs diseaseNeuroReport, 1997
- Cerebrospinal Fluid Tau Levels in Neurodegenerative Diseases with Distinct Tau-Related PathologyBiochemical and Biophysical Research Communications, 1997
- tau protein in cerebrospinal fluidMolecular and Chemical Neuropathology, 1995
- The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressureJournal of the Neurological Sciences, 1965